1. Home
  2. NVNI vs BNGO Comparison

NVNI vs BNGO Comparison

Compare NVNI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nvni Group Limited

NVNI

Nvni Group Limited

N/A

Current Price

$0.94

Market Cap

10.9M

Sector

N/A

ML Signal

N/A

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

N/A

Current Price

$1.60

Market Cap

12.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NVNI
BNGO
Founded
2019
2003
Country
Brazil
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
12.5M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
NVNI
BNGO
Price
$0.94
$1.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.1K
★ 2.5M
Earning Date
09-21-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 94.50
EPS
★ N/A
N/A
Revenue
N/A
★ $12,000,735.00
Revenue This Year
$0.05
$12.73
Revenue Next Year
$10.26
$34.74
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 26.26
52 Week Low
$0.31
$1.00
52 Week High
$4.94
$2.23

Technical Indicators

Market Signals
Indicator
NVNI
BNGO
Relative Strength Index (RSI) 45.28 57.10
Support Level $0.78 $1.10
Resistance Level $1.28 $1.68
Average True Range (ATR) 0.07 0.21
MACD 0.00 -0.01
Stochastic Oscillator 39.78 37.94

Price Performance

Historical Comparison
NVNI
BNGO

About NVNI Nvni Group Limited

Nvni Group Ltd, through its existing subsidiary companies, operates business-to-business software-as-a-service (B2B SaaS) products in Brazil, serving a diversified customer base of small and mid-sized enterprises across vertical markets. The Group's core business activity is providing a SaaS platform model focused on the software delivery method of cloud-based software applications to its customers. The Group generates revenues and profits from SaaS platform subscription services, data analytics services, set-up and other services. The Group has a single operating and reportable segment, multi-vertical SaaS solution model. The Group operates and generates revenue from Brazil.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: